Insider · CIK 0001866025
Kantoff Philip W.
Reports to the SEC for 2 companies · PHILADELPHIA, PA
Transactions
6
Companies
2
Filings
6
CIK
0001866025
Forms 4 and 5
Insider transactions
| Date | Company | Value |
|---|---|---|
| 2026-06-24 | CNTXContext Therapeutics Inc. · Stock Option (right to buy)A Award | — |
| 2025-06-12 | CNTXContext Therapeutics Inc. · Stock Option (right to buy)A Award | — |
| 2024-06-13 | CNTXContext Therapeutics Inc. · Stock Option (right to buy)A Award | — |
| 2024-03-25 | EPIXESSA Pharma Inc. · OptionsA Award | — |
| 2023-05-31 | CNTXContext Therapeutics Inc. · Stock Option (right to buy)A Award | — |
| 2022-06-02 | CNTXContext Therapeutics Inc. · Stock Option (right to buy)A Award | — |
Recent filings
- 4Kantoff Philip W.0001628280-26-045762SEC(opens sec.gov)
- 4Kantoff Philip W.0001842952-25-000077SEC(opens sec.gov)
- 4Kantoff Philip W.0001842952-24-000046SEC(opens sec.gov)
- 4Kantoff Philip W.0000950172-24-000135SEC(opens sec.gov)
- 4Kantoff Philip W.0001842952-23-000062SEC(opens sec.gov)
- 4Kantoff Philip W.0001842952-22-000059SEC(opens sec.gov)
Companies
Address
2001 MARKET STREET SUITE 3915, UNIT #15
PHILADELPHIA, PA, 19103